Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD7268 in Major Depressive Disorder
NCT01020799Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azd-7268 in major depressive disorder (MDD), sponsored by AstraZeneca. Started Nov 2009; status: completed.
02
Drugs
azd-7268
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01020799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01020799.